- Home
- LIN vs NVS Comparison
LIN vs NVS Comparison
Compare LIN & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LIN | NVS |
|---|---|---|
| Founded | 1879 | 1895 |
| Country | United Kingdom | Switzerland |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.1B | 261.7B |
| IPO Year | 2017 | 2001 |
Fundamental Metrics
Financial Performance| Metric | LIN | NVS |
|---|---|---|
| Price | $492.64 | $146.84 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 29 | 12 |
| Target Price | ★ $544.30 | $154.65 |
| AVG Volume (30 Days) | ★ 1.9M | 1.6M |
| Earning Date | 10-29-2026 | 10-27-2026 |
| Dividend Yield | 1.30% | ★ 2.16% |
| EPS Growth | ★ 7.27 | N/A |
| EPS | ★ 8.13 | N/A |
| Revenue | ★ $33,986,000,000.00 | N/A |
| Revenue This Year | $6.92 | $1.72 |
| Revenue Next Year | $4.87 | $6.42 |
| P/E Ratio | $60.53 | ★ $23.13 |
| Revenue Growth | ★ 2.97 | N/A |
| 52 Week Low | $387.78 | $121.57 |
| 52 Week High | $548.20 | $170.46 |
Technical Indicators
Market Signals| Indicator | LIN | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 63.81 | 55.72 |
| Support Level | $487.51 | $145.95 |
| Resistance Level | $497.42 | $153.63 |
| Average True Range (ATR) | 6.91 | 1.91 |
| MACD | 2.64 | 0.78 |
| Stochastic Oscillator | 95.01 | 95.86 |
Price Performance
Historical ComparisonAbout LIN Linde plc
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $34 billion in revenue in 2025.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.